Literature DB >> 19504183

Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer.

Najim Ameziane, Ans M W van den Ouweland, Muriel A Adank, Raymond N C P Vijzelaar, Abdellatif Errami, Josephine C Dorsman, Hans Joenje, Hanne Meijers-Heijboer, Quinten Waisfisz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19504183     DOI： 10.1007/s10549-009-0428-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  6 in total

1.  Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated.

Authors:  Femme Harinck; Irma Kluijt; Saskia E van Mil; Quinten Waisfisz; Theo A M van Os; Cora M Aalfs; Anja Wagner; Maran Olderode-Berends; Rolf H Sijmons; Ernst J Kuipers; Jan-Werner Poley; Paul Fockens; Marco J Bruno
Journal:  Eur J Hum Genet       Date:  2011-12-14       Impact factor: 4.246

2.  Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families.

Authors:  Szilvia Solyom; Katri Pylkäs; Robert Winqvist
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

3.  Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer.

Authors:  Marc D Tischkowitz; Nelly Sabbaghian; Nancy Hamel; Ayelet Borgida; Chaim Rosner; Nassim Taherian; Archana Srivastava; Spring Holter; Heidi Rothenmund; Parviz Ghadirian; William D Foulkes; Steven Gallinger
Journal:  Gastroenterology       Date:  2009-07-25       Impact factor: 22.682

4.  Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.

Authors:  Katsutoshi Sato; Mio Koyasu; Sachio Nomura; Yuri Sato; Mizuho Kita; Yuumi Ashihara; Yasue Adachi; Shinji Ohno; Takuji Iwase; Dai Kitagawa; Eri Nakashima; Reiko Yoshida; Yoshio Miki; Masami Arai
Journal:  Cancer Sci       Date:  2017-09-18       Impact factor: 6.716

5.  BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.

Authors:  F Z Francies; T Wainstein; K De Leeneer; A Cairns; M Murdoch; S Nietz; H Cubasch; B Poppe; T Van Maerken; B Crombez; I Coene; R Kerr; J P Slabbert; A Vral; A Krause; A Baeyens; K B M Claes
Journal:  BMC Cancer       Date:  2015-11-17       Impact factor: 4.430

6.  Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer.

Authors:  Haeyoung Kim; Dae-Yeon Cho; Doo Ho Choi; Gee Hue Jung; Inkyung Shin; Won Park; Seung Jae Huh; Seok Jin Nam; Jeong Eon Lee; Won Ho Gil; Seok Won Kim
Journal:  Cancer Res Treat       Date:  2016-01-19       Impact factor: 4.679
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.